Literature DB >> 23065747

Central venous oxygen saturation during cardiopulmonary bypass predicts 3-year survival.

Staffan Svenmarker1, Sören Häggmark, Margareta Östman, Anders Holmgren, Ulf Näslund.   

Abstract

OBJECTIVES: Long-term survival after cardiac surgery is determined by a number of different risk factors. Central venous oxygen saturation (S(v)O(2)) measures the balance between oxygen delivery and demand. S(v)O(2) levels in the intensive care situation are reported to be associated with patient outcome. The present report explores the connection between S(v)O(2) during cardiopulmonary bypass (CPB) and survival after cardiac surgery.
METHODS: Retrospective analysis of one thousand consecutive cardiac surgical patients was undertaken. S(v)O(2) during CPB was monitored online. Registry data combining specific risk factors with S(v)O(2) were selected for Kaplan-Meier and Cox regression analysis to examine the influence on 30-day and 3-year survivals.
RESULTS: Nine-hundred and thirty-two patient records were eligible for analysis. S(v)O(2) below 75% during CPB was associated with significantly shorter 30-day and 3-year survivals. Based on Kaplan-Meier statistics, the survival rate decreased by 3.1% (98.1-95.0), P = 0.011 and 6.1% (92.7-86.6), P = 0.003, respectively. The influence of S(v)O(2) on 3-year survival remained statistically significant after controlling for a series of risk factors in the Cox regression analysis. Patients with S(v)O(2) <75% carried a 2-fold (odds ratio 2.1) increased relative risk of shortened 3-year survival (P = 0.003). Other risk factors statistically significantly associated with 3-year survival were age, gender, duration of CPB, blood temperature, hypertension, haematocrit and type of surgical procedure.
CONCLUSIONS: We report decreased 30-day and 3-year survival expectancy for patients experiencing S(v)O(2) lower than 75% during CPB.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23065747      PMCID: PMC3523619          DOI: 10.1093/icvts/ivs363

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  25 in total

1.  Relationship between anesthetic depth and venous oxygen saturation during cardiopulmonary bypass.

Authors:  Erica J Stein; David B Glick; Mohammed M Minhaj; Melinda Drum; Avery Tung
Journal:  Anesthesiology       Date:  2010-07       Impact factor: 7.892

2.  Mixed venous oxygen saturation is a prognostic marker after surgery for aortic stenosis.

Authors:  J Holm; R E Håkanson; F Vánky; R Svedjeholm
Journal:  Acta Anaesthesiol Scand       Date:  2010-01-18       Impact factor: 2.105

3.  Role of central and mixed venous oxygen saturation measurement in perioperative care.

Authors:  Stephen J Shepherd; Rupert M Pearse
Journal:  Anesthesiology       Date:  2009-09       Impact factor: 7.892

4.  A metabolic protective strategy could improve long-term survival in patients with LV-dysfunction undergoing CABG.

Authors:  Rolf Svedjeholm; Mårten Vidlund; Ingemar Vanhanen; Erik Håkanson
Journal:  Scand Cardiovasc J       Date:  2010-02       Impact factor: 1.589

5.  Impact of the Surviving Sepsis Campaign protocols on hospital length of stay and mortality in septic shock patients: results of a three-year follow-up quasi-experimental study.

Authors:  Alvaro Castellanos-Ortega; Borja Suberviola; Luis A García-Astudillo; María S Holanda; Fernando Ortiz; Javier Llorca; Miguel Delgado-Rodríguez
Journal:  Crit Care Med       Date:  2010-04       Impact factor: 7.598

Review 6.  Venous oxygen saturation as a physiologic transfusion trigger.

Authors:  Benoit Vallet; Emmanuel Robin; Gilles Lebuffe
Journal:  Crit Care       Date:  2010-03-09       Impact factor: 9.097

7.  Central venous oxygen saturation and blood lactate levels during cardiopulmonary bypass are associated with outcome after pediatric cardiac surgery.

Authors:  Marco Ranucci; Giuseppe Isgrò; Concetta Carlucci; Teresa De La Torre; Stefania Enginoli; Alessandro Frigiola
Journal:  Crit Care       Date:  2010-08-04       Impact factor: 9.097

Review 8.  Optimal perfusion during cardiopulmonary bypass: an evidence-based approach.

Authors:  Glenn S Murphy; Eugene A Hessel; Robert C Groom
Journal:  Anesth Analg       Date:  2009-05       Impact factor: 5.108

9.  Static blood-flow control during cardiopulmonary bypass is a compromise of oxygen delivery.

Authors:  Staffan Svenmarker; Sören Häggmark; Magnus Hultin; Anders Holmgren
Journal:  Eur J Cardiothorac Surg       Date:  2009-07-29       Impact factor: 4.191

10.  Multicenter study of central venous oxygen saturation (ScvO(2)) as a predictor of mortality in patients with sepsis.

Authors:  Jennifer V Pope; Alan E Jones; David F Gaieski; Ryan C Arnold; Stephen Trzeciak; Nathan I Shapiro
Journal:  Ann Emerg Med       Date:  2009-10-25       Impact factor: 5.721

View more
  4 in total

1.  High central venous saturation after cardiac surgery is associated with increased organ failure and long-term mortality: an observational cross-sectional study.

Authors:  Felix Balzer; Michael Sander; Mark Simon; Claudia Spies; Marit Habicher; Sascha Treskatsch; Viktor Mezger; Uwe Schirmer; Matthias Heringlake; Klaus-Dieter Wernecke; Herko Grubitzsch; Christian von Heymann
Journal:  Crit Care       Date:  2015-04-16       Impact factor: 9.097

2.  Regional cerebral oxygen saturation and postoperative delirium in endovascular surgery: a prospective cohort study.

Authors:  Xiaohua Wang; Kunpeng Feng; Haixia Liu; Yanhui Liu; Ming Ye; Guoguang Zhao; Tianlong Wang
Journal:  Trials       Date:  2019-08-14       Impact factor: 2.279

3.  Non-invasively Measured Venous Oxygen Saturation as Early Marker of Impaired Oxygen Delivery in Preterm Neonates.

Authors:  Lukas P Mileder; Julia Buchmayer; Nariae Baik-Schneditz; Bernhard Schwaberger; Nina Höller; Chad C Andersen; Michael J Stark; Gerhard Pichler; Berndt Urlesberger
Journal:  Front Pediatr       Date:  2022-01-28       Impact factor: 3.418

4.  Peripheral measurements of venous oxygen saturation and lactate as a less invasive alternative for hemodynamic monitoring.

Authors:  Raphaelle Avigael Chemtob; Hasse Møller-Sørensen
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2018-09-10       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.